Neuromodulation trials

Study to Compare the Clinical Effectiveness and Cost Utility of an All-in-one Procedure With an At-home Screening Trial

RecruitingNCT06996574Phase: NAStarted 2025-06-06

Summary

In 2019, the Dutch Healthcare Institute published a consensus report outlining when spinal cord stimulation (SCS) for chronic pain qualifies for reimbursement under Dutch health insurance. It mandates

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Locations

Amsterdam UMCAmsterdam, Netherlands

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06996574